MedTrace Logo

In Vitro Interaction Between Ticagrelor and Its Active Metabolite and Their Effects on Salicylic Acid

NCT01777516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2013-01-29

No results posted yet for this study

Summary

This is a in-vitro study to evaluate the pharmacodynamic interaction between ticagrelor and its active metabolite (AR-C124910XX) and their effects on the pharmacodynamics of salicylic acid. The study consist of two parts of in-vitro study as follows;

* Part 1 : in-vitro study to evaluate the pharmacodynamic interaction between ticagrelor and its active metabolite.
* Part 2 : in vitro study to evaluate the pharmacodynamic interaction between ticagrelor and its active metabolite and their effect on the pharmacodynamics of salicylic acid on platelet aggregation tests with the agonist of arachidonic acid.

Conditions

Sponsors & Collaborators

  • Korea National Enterprise for Clinical Trials

    collaborator OTHER

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Hyeong-Seok Lim, M.D., PhD · Asan Medical Center

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01777516 on ClinicalTrials.gov